Donna E. Hogge

Haematology

Email Address

dhogge@bccancer.bc.ca

Phone

604-675-8138

Mailing Address

Vancouver BCCA

Biography

Academic Appointment

Clinical Professor

Clinical Trials

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia (301)

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML) (VALOR)